[Effect of antiviral therapy on the occurrence of hepatitis B-related hepatocellular carcinoma].

Jun Sun, S Zhang, Wang Yx, L. Zhu, Xing HcPubMed 2019 · DOI

Abstract

Clinically, hepatocellular carcinoma (HCC) is one of the most common malignant tumors with a high rate of morbidity and mortality. Hepatitis B virus infection is the main cause of hepatocellular carcinoma in China and it is a serious threat to people's health. Antiviral drugs such as nucleos(t)ide analogues and interferon can inhibit viral replication and liver fibrosis progression and reduce the occurrence of hepatitis B-related HCC. This article reviews the effects of different antiviral therapy on the occurrence of hepatitis B-related hepatocellular carcinoma in recent years.
BibTeX
@inproceedings{sun2019effect,
  author = {Jun Sun and S Zhang and Wang Yx and L. Zhu and Xing Hc},
  title = {{[Effect of antiviral therapy on the occurrence of hepatitis B-related hepatocellular carcinoma].}},
  booktitle = {PubMed},
  year = {2019},
  doi = {10.3760/cma.j.issn.1007-3418.2019.09.014},
}

Loading related content...

Figure